Targeting Tumor Microenvironment-Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer.
利用 Zenocutuzumab 靶向肿瘤微环境衍生的 NRG1-HER2/3 信号通路,可恢复 PTEN 野生型前列腺癌对 AR 抑制剂的敏感性。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-25-0505
Shinder Brian M, Lee Young Sun, Mao Ninghui, Salsabeel Nazifa, Zhang Zeda, Kaur Harmanpreet, Chen Xiaoping, Chang Qing, de Stanchina Elisa, Gopalan Anuradha, Sawyers Charles L, Carver Brett S